Osteoarthritis playing up? New Australian study finds Palmitoylethanolamide (PEA) could be the answer

A new 2019 Australian study has found an extract made from soy, eggs and peanuts significantly reduces pain and stiffness when taken by sufferers of knee osteoarthritis. Palmitoylethanolamide (PEA) was given to 111 participants in the study conducted by researchers from The University of Sydney, University of the Sunshine Coast, Queensland University of Technology and 

Continue Reading…

New study suggests Palmitoylethanolamide (PEA) could be breakthrough treatment for Alzheimers

A new study has found that N-Palmitoylethanolamide (PEA), a curious organic compound increasingly attracting the interest of medical researchers, greatly reduces symptoms of Alzheimers Disease (AD) in animals. The study, conducted by scientists from the University of Ferrara in Italy and published in Frontiers, looked at pre-clinical data from both in vitro and in vivo 

Continue Reading…

New study finds Palmitoylethanolamide (PEA) could offer hope to sufferers of Fibromyalgia

A newly released observational study conducted by researchers from the Verona University Hospital in Italy has suggested that a substance currently classified as a food product could potentially offer hope to sufferers of Fibromyalgia. In the study, data from 407 fibromyalgia patients who had been prescribed ultramicronized Palmitoylethanolamide (PEA) tablets between the years 2013 and 

Continue Reading…

Drug manufacturer to launch commercial version of ‘natural painkiller’ Palmitoylethanolamide (PEA)

A large U.S. pharmaceutical company is preparing to go to market with a mass-produced commercial version of a natural pain management supplement that compounding pharmacies in Australia have been providing to integrative doctors and their patients for many years – Palmitoylethanolamide, or PEA. In November the drug manufacturer, Gencor, announced it had recently completed a 

Continue Reading…

Forgotten pain-killing drug could fill gap in the market left by codeine crackdown

With codeine products no longer available over the counter at Australian chemists from today (1 Feb 2018), the compounding pharmacy sector may have a gentler, non-addictive answer for sufferers of chronic pain. The alternative pain-killing medication has a name that’s enough to cause you some additional pain – Palmitoylethanolamide. In clinical trials, this curious old 

Continue Reading…